跳至主要内容
临床试验/NCT04448002
NCT04448002已完成不适用

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

University of Florida2 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2021年4月23日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
320
试验地点
2
主要终点
Asthma Control using asthma control questionnaire

研究概览

简要总结

The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adolescent is 12-15 years old
  • Caregiver is between 18-70 years-old
  • Adolescent lives in the residence of caregiver
  • Adolescent and caregiver can speak and read English
  • (a) Adolescent has been diagnosed as having asthma, OR (b) Doctor has stated the adolescent has asthma, OR (c) Adolescent has had breathing problems in the past 12 months
  • Adolescent has had an active inhaled corticosteroid prescription for ≥ 4 weeks
  • (a) During the past 14 days (that is, during the past fourteen 24-hour periods that include daytime and nighttime), the adolescent has experienced one or more of the following: (i) Asthma symptoms such as wheezing, shortness of breath, or tightness in the chest, or cough on more than 4 separate days; (ii) Woken up because of asthma symptoms such as wheezing, shortness of breath, or tightness in the chest, or cough on 1 or more separate nights; (iii) Had to slow down or stop play or usual activities or missed school because of asthma, wheezing, or tightness in the chest, or cough on more than 4 separate days; (iv) Used any asthma rescue medicine (sometimes called a quick relief medicine) on more than 4 separate days
  • (b) In the past year, adolescent has had one or more of the following: (i) 2 or more exacerbations requiring oral systemic corticosteroids; (ii) 2 or more emergency department visits; (iii) 1 hospitalization; (iv) 2 or more urgent medical care visits due to asthma
  • (c) Adolescent scores 19 or lower on the Asthma Control Test

排除标准

  • Families will be excluded if:
  • The family is currently involved in an asthma management intervention above and beyond usual care, OR
  • Adolescent is unable to complete study procedures independently.

研究组 & 干预措施

AIM2ACT

Experimental

AIM2ACT is the experimental arm for the trial. AIM2ACT is a dyadic mHealth intervention designed to sustain caregiver involvement and monitoring as well as guide dyads through collaborative asthma management.

干预措施: AIM2ACT (Behavioral)

mHealth Attention Control Condition

Active Comparator

The mHealth attention control condition is the active comparator arm in the trial that accounts for staff attention and novelty of technology based asthma management intervention.

干预措施: mHealth Attention Control Condition (Behavioral)

结局指标

主要结局

Asthma Control using asthma control questionnaire

时间窗: Change in baseline, post-intervention,3 months, and 6 months, and 12 month follow-up

Measured via the Asthma Control Test questionnaire which has 5 items that assesses frequency of daytime and nocturnal asthma symptoms, activity limitations, and perceptions of disease control.Adolescents will complete all 5 items independently of caregivers. Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score \>19 indicates well-controlled asthma."

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验